首頁 > 市場調查報告書 > 製藥

個人化醫學

市場調查報告書

商品編碼

1900397

精準醫療軟體市場規模、佔有率及成長分析（按交付類型、應用、最終用戶和地區分類）－2026-2033年產業預測

Precision Medicine Software Market Size, Share, and Growth Analysis, By Delivery Mode (Web & Cloud-Based, On-Premises), By Application (Oncology, Pharmacogenomics), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，精準醫療軟體市場規模將達到 16.2 億美元，到 2025 年將達到 18 億美元，到 2033 年將達到 42.8 億美元，在預測期（2026-2033 年）內，複合年成長率將達到 11.4%。

精準醫療軟體市場正經歷強勁成長，這主要得益於技術進步和對個人化醫療解決方案日益成長的需求。該軟體使醫療服務提供者能夠有效地收集、分析和利用大量的患者數據，從而製定個人化的治療方案，充分考慮個體的遺傳、環境和生活方式等因素。關鍵成長要素包括慢性病發病率的上升、基因組學和蛋白質組學的進步、電子健康記錄（EHR）的日益普及以及政府的積極支持。此外，將人工智慧（AI）和機器學習演算法整合到精準醫療軟體中，預計將進一步加速市場發展，為不斷變化的醫療環境中的創新創造機遇，並有助於改善患者的治療效果。

精準醫療軟體市場促進因素

推動精準醫療軟體市場成長的關鍵因素之一是人們對個人化醫療解決方案日益成長的需求。精準醫療專注於根據個體獨特的基因組成、生活方式選擇和環境影響，提供客製化的治療和介入措施。先進的基因測序技術與巨量資料分析能力的結合，正在促進精準醫療融入日常臨床實務。精準醫療軟體使醫療服務提供者能夠處理大量的患者數據，包括基因圖譜、病歷和即時監測數據，從而做出更個人化和明智的治療決策。患者和醫療專業人員對精準醫療益處的認知不斷提高，進一步推動了對輔助軟體解決方案的需求。

精準醫療軟體市場面臨的限制因素

精準醫療軟體市場面臨的主要挑戰之一是其複雜且高成本的實施和整合過程。滿足精準醫療的需求需要全面的軟體解決方案來收集、儲存和分析大量的基因組和臨床數據。然而，醫療機構常常受到互通性挑戰、資料隱私問題以及醫務人員需要接受大量培訓等問題的阻礙。資金挑戰也是一大障礙。實施、維護和升級這些複雜軟體系統的成本可能非常高昂，尤其對於小規模的醫療機構和資源匱乏的地區而言，這可能會阻礙它們採用這些創新技術。

精準醫療軟體市場趨勢

精準醫療軟體市場目前正受到多項變革性趨勢的影響，這些趨勢正在強化其結構。其中顯著的趨勢包括人工智慧 (AI) 和機器學習 (ML) 技術的日益普及，這些技術能夠提高診斷準確性，並根據患者的個別特徵量身定做治療方案。此外，向雲端解決方案的轉型勢頭強勁，有助於在安全的環境中高效儲存、分析和共享海量的基因組和臨床數據共用。同時，互通性和數據標準化也日益受到重視，這有助於整合不同的醫療保健系統，並加強醫療專業人員之間的協作。這些趨勢正在匯聚，推動精準醫療軟體功能的持續發展，最終目標是改善患者照護和健康結果。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

IBM Watson Health
Oracle Corporation
SAP SE
SAS Institute Inc.
Microsoft Corporation
Flatiron Health, Inc.
Syapse, Inc.
Fabric Genomics, Inc.
N-of-One, Inc.
Gene42, Inc.
PierianDx
LifeOmic
Tempus Labs, Inc.
2bPrecise LLC
Human Longevity, Inc.
GNS Healthcare
Seven Bridges Genomics
WuXi NextCODE
Foundation Medicine, Inc.
Strand Life Sciences

結論與建議

簡介目錄

Product Code: SQMIG35G2224

Precision Medicine Software Market size was valued at USD 1.62 Billion in 2024 and is poised to grow from USD 1.8 Billion in 2025 to USD 4.28 Billion by 2033, growing at a CAGR of 11.4% during the forecast period (2026-2033).

The precision medicine software market is witnessing robust growth, fueled by technological advancements and a rising demand for personalized healthcare solutions. This software empowers healthcare providers to efficiently gather, analyze, and apply extensive patient data, allowing for customized treatment plans that consider individual genetic, environmental, and lifestyle variables. Critical growth drivers include the increasing prevalence of chronic diseases, progress in genomics and proteomics, a surge in electronic health record adoption, and favorable government support. Additionally, the incorporation of artificial intelligence and machine learning algorithms into precision medicine software is poised to enhance market momentum, creating further opportunities for innovation and improved patient outcomes in the evolving healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Precision Medicine Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Precision Medicine Software Market Segments Analysis

Global Precision Medicine Software Market is segmented by delivery mode, application, end user and region. Based on delivery mode, the market is segmented into web & cloud-based and on-premises. Based on application, the market is segmented into oncology, pharmacogenomics and rare diseases. Based on end user, the market is segmented into healthcare providers, research centers and academic institutes and pharmaceutical and biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Precision Medicine Software Market

A significant factor propelling the growth of the precision medicine software market is the rising demand for personalized healthcare solutions. Precision medicine focuses on delivering tailored treatments and interventions based on an individual's unique genetic composition, lifestyle choices, and environmental influences. The emergence of sophisticated genomic sequencing technologies, coupled with the capabilities of big data analytics, has enhanced the integration of precision medicine into everyday clinical practice. Precision medicine software empowers healthcare providers to process extensive patient data, including genetic profiles, medical histories, and real-time monitoring, enabling them to make more customized and informed treatment decisions. Increased awareness among patients and healthcare professionals about the advantages of precision medicine further fuels the demand for supportive software solutions.

Restraints in the Precision Medicine Software Market

One significant challenge facing the precision medicine software market is the intricate and costly nature of its implementation and integration processes. The demands of precision medicine require comprehensive software solutions for collecting, storing, and analyzing extensive genomic and clinical data. However, healthcare organizations often encounter difficulties due to interoperability challenges, data privacy issues, and the necessity for thorough training of healthcare staff. The financial aspect also poses a barrier, as the expenses related to acquiring, maintaining, and upgrading these sophisticated software systems can be prohibitively high, particularly for smaller healthcare facilities and regions with limited resources, thereby hindering their ability to adopt such innovative technologies.

Market Trends of the Precision Medicine Software Market

The precision medicine software market is currently influenced by several transformative trends that are enhancing its landscape. A notable trend is the rising incorporation of artificial intelligence (AI) and machine learning (ML) technologies, which boost diagnostic accuracy and enable the customization of treatment strategies based on individual patient profiles. Additionally, the shift towards cloud-based solutions is gaining momentum, facilitating efficient storage, analysis, and sharing of extensive genomic and clinical datasets in a secure environment. There is also an increasing emphasis on interoperability and data standardization, which enhances the integration of diverse healthcare systems and fosters collaboration among medical professionals. These trends are collectively propelling the evolving capabilities of precision medicine software, ultimately aiming to improve patient care and health outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Patent Analysis
Case Studies

Global Precision Medicine Software Market Size by Delivery Mode & CAGR (2026-2033)

Market Overview
Web & Cloud-Based
On-Premises

Global Precision Medicine Software Market Size by Application & CAGR (2026-2033)

Market Overview
Oncology
Pharmacogenomics
Rare Diseases

Global Precision Medicine Software Market Size by End User & CAGR (2026-2033)

Market Overview
Healthcare Providers
Research Centers and Academic Institutes
Pharmaceutical and Biotechnology Companies

Global Precision Medicine Software Market Size & CAGR (2026-2033)

North America (Delivery Mode, Application, End User)
- US
- Canada
Europe (Delivery Mode, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific (Delivery Mode, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America (Delivery Mode, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Delivery Mode, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

IBM Watson Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oracle Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SAP SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SAS Institute Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microsoft Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Flatiron Health, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syapse, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fabric Genomics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
N-of-One, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gene42, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PierianDx
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeOmic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tempus Labs, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
2bPrecise LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Human Longevity, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GNS Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seven Bridges Genomics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi NextCODE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Foundation Medicine, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Strand Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments